142 related articles for article (PubMed ID: 36934306)
1. Long-term outcomes in Hodgkin lymphoma survivors. Temporary trends and comparison with general population.
Núñez-García B; Clemente MB; Sánchez JC; Royuela A; Ibargüen BCS; Méndez M; López-Ibor JV; Martínez M; Traseira C; Garitaonaindia Y; Aguado R; Calvo V; Torrente M; Parejo C; Provencio Z; Provencio M
Hematol Oncol; 2023 Aug; 41(3):407-414. PubMed ID: 36934306
[TBL] [Abstract][Full Text] [Related]
2. Long-Term Cause-Specific Mortality in Hodgkin Lymphoma Patients.
de Vries S; Schaapveld M; Janus CPM; Daniëls LA; Petersen EJ; van der Maazen RWM; Zijlstra JM; Beijert M; Nijziel MR; Verschueren KMS; Kremer LCM; van Eggermond AM; Lugtenburg PJ; Krol ADG; Roesink JM; Plattel WJ; van Spronsen DJ; van Imhoff GW; de Boer JP; Aleman BMP; van Leeuwen FE
J Natl Cancer Inst; 2021 Jun; 113(6):760-769. PubMed ID: 33351090
[TBL] [Abstract][Full Text] [Related]
3. Risk of solid subsequent malignant neoplasms after childhood Hodgkin lymphoma-Identification of high-risk populations to guide surveillance: A report from the Late Effects Study Group.
Holmqvist AS; Chen Y; Berano Teh J; Sun C; Birch JM; van den Bos C; Diller LR; Dilley K; Ginsberg J; Martin LT; Nagarajan R; Nathan PC; Neglia JP; Terenziani M; Tishler D; Meadows AT; Robison LL; Oberlin O; Bhatia S
Cancer; 2019 Apr; 125(8):1373-1383. PubMed ID: 30556153
[TBL] [Abstract][Full Text] [Related]
4. Morbidity and mortality in long-term survivors of Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study.
Castellino SM; Geiger AM; Mertens AC; Leisenring WM; Tooze JA; Goodman P; Stovall M; Robison LL; Hudson MM
Blood; 2011 Feb; 117(6):1806-16. PubMed ID: 21037086
[TBL] [Abstract][Full Text] [Related]
5. Subsequent malignancies among long-term survivors of Hodgkin lymphoma and non-Hodgkin lymphoma: a pooled analysis of German cancer registry data (1990-2012).
Baras N; Dahm S; Haberland J; Janz M; Emrich K; Kraywinkel K; Salama A
Br J Haematol; 2017 Apr; 177(2):226-242. PubMed ID: 28106907
[TBL] [Abstract][Full Text] [Related]
6. Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study.
Hisada M; Chen BE; Jaffe ES; Travis LB
J Natl Cancer Inst; 2007 Feb; 99(3):215-22. PubMed ID: 17284716
[TBL] [Abstract][Full Text] [Related]
7. Risk of Second Cancer in Hodgkin Lymphoma Survivors and Influence of Family History.
Sud A; Thomsen H; Sundquist K; Houlston RS; Hemminki K
J Clin Oncol; 2017 May; 35(14):1584-1590. PubMed ID: 28384078
[TBL] [Abstract][Full Text] [Related]
8. [SENTIERI - Epidemiological Study of Residents in National Priority Contaminated Sites. Sixth Report].
Zona A; Fazzo L; Benedetti M; Bruno C; Vecchi S; Pasetto R; Minichilli F; De Santis M; Nannavecchia AM; Di Fonzo D; Contiero P; Ricci P; Bisceglia L; Manno V; Minelli G; Santoro M; Gorini F; Ancona C; Scondotto S; Soggiu ME; Scaini F; Beccaloni E; Marsili D; Villa MF; Maifredi G; Magoni M; Iavarone I;
Epidemiol Prev; 2023; 47(1-2 Suppl 1):1-286. PubMed ID: 36825373
[TBL] [Abstract][Full Text] [Related]
9. Second malignant neoplasms in survivors of pediatric Hodgkin's lymphoma treated with low-dose radiation and chemotherapy.
O'Brien MM; Donaldson SS; Balise RR; Whittemore AS; Link MP
J Clin Oncol; 2010 Mar; 28(7):1232-9. PubMed ID: 20124178
[TBL] [Abstract][Full Text] [Related]
10. Late mortality, secondary malignancy and hospitalisation in teenage and young adult survivors of Hodgkin lymphoma: report of the Childhood/Adolescent/Young Adult Cancer Survivors Research Program and the BC Cancer Agency Centre for Lymphoid Cancer.
Bhuller KS; Zhang Y; Li D; Sehn LH; Goddard K; McBride ML; Rogers PC
Br J Haematol; 2016 Mar; 172(5):757-68. PubMed ID: 26727959
[TBL] [Abstract][Full Text] [Related]
11. Long-term complications in Hodgkin's lymphoma survivors.
Kilickap S; Barista I; Ulger S; Celik I; Selek U; Güllü I; Yildiz F; Kars A; Ozisik Y; Tekuzman G
Tumori; 2012; 98(5):601-6. PubMed ID: 23235755
[TBL] [Abstract][Full Text] [Related]
12. Second primary head and neck cancer after Hodgkin lymphoma: a population-based study of 44,879 survivors of Hodgkin lymphoma.
Chowdhry AK; McHugh C; Fung C; Dhakal S; Constine LS; Milano MT
Cancer; 2015 May; 121(9):1436-45. PubMed ID: 25572913
[TBL] [Abstract][Full Text] [Related]
13. Late morbidity and mortality in patients with Hodgkin's lymphoma treated during adulthood.
Matasar MJ; Ford JS; Riedel ER; Salz T; Oeffinger KC; Straus DJ
J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25717170
[TBL] [Abstract][Full Text] [Related]
14. Trends and Disparities in Cardiovascular Mortality Among Survivors of Hodgkin Lymphoma.
Al-Kindi SG; Abu-Zeinah GF; Kim CH; Hejjaji V; William BM; Caimi PF; Oliveira GH
Clin Lymphoma Myeloma Leuk; 2015 Dec; 15(12):748-52. PubMed ID: 26324747
[TBL] [Abstract][Full Text] [Related]
15. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer.
van den Belt-Dusebout AW; de Wit R; Gietema JA; Horenblas S; Louwman MW; Ribot JG; Hoekstra HJ; Ouwens GM; Aleman BM; van Leeuwen FE
J Clin Oncol; 2007 Oct; 25(28):4370-8. PubMed ID: 17906202
[TBL] [Abstract][Full Text] [Related]
16. Sociodemographic disparities in the occurrence of medical conditions among adolescent and young adult Hodgkin lymphoma survivors.
Keegan THM; Li Q; Steele A; Alvarez EM; Brunson A; Flowers CR; Glaser SL; Wun T
Cancer Causes Control; 2018 Jun; 29(6):551-561. PubMed ID: 29654427
[TBL] [Abstract][Full Text] [Related]
17. Risk of second breast cancer in female Hodgkin's lymphoma survivors: a meta-analysis.
Ibrahim EM; Abouelkhair KM; Kazkaz GA; Elmasri OA; Al-Foheidi M
BMC Cancer; 2012 May; 12():197. PubMed ID: 22639888
[TBL] [Abstract][Full Text] [Related]
18. Long-term risk of second malignancy and cardiovascular disease after Hodgkin lymphoma treatment.
van Leeuwen FE; Ng AK
Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):323-330. PubMed ID: 27913498
[TBL] [Abstract][Full Text] [Related]
19. Fatigue level changes with time in long-term Hodgkin and non-Hodgkin lymphoma survivors: a joint EORTC-LYSA cross-sectional study.
Busson R; van der Kaaij M; Mounier N; Aleman BMP; Thiéblemont C; Stamatoullas A; Ribrag V; Tilly H; Haioun C; Casasnovas RO; Kluin-Nelemans HC; Henry-Amar M
Health Qual Life Outcomes; 2019 Jul; 17(1):115. PubMed ID: 31266501
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer and cardiovascular outcomes after breast cancer in survivors of Hodgkin lymphoma.
Krul IM; Boekel NB; Kramer I; Janus CPM; Krol ADG; Nijziel MR; Zijlstra JM; van der Maazen RWM; Roesink JM; Jacobse JN; Schaapveld M; Schmidt MK; Opstal-van Winden AWJ; Sonke GS; Russell NS; Aleman BMP; van Leeuwen FE
Cancer; 2022 Dec; 128(24):4285-4295. PubMed ID: 36281718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]